Clinical Trial Update: N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for N-Acetylcysteine as therapy for transplant-associated thrombotic microangiopathy, a Phase 2/Phase 3 study sponsored by The First Affil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transplant-associated Thrombotic Microangiopathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Thrombotic Microangiopathy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING